|Pre-sale Time:||27 Jul, 2018 - 31 Aug, 2018|
|ICO Time:||1 Sep, 2018 - 20 Sep, 2018|
|Whitelist/KYC:||Whitelist & Kyc|
|Available for sale:||600,000,000 AEN|
|ICO Price:||1 AEN = 0.1 USD|
|Soft cap:||15,000,000 USD|
|Hard cap:||60,000,000 USD|
Aeneas Capital grante Asset Management license by SFC (Hong Kong).
Fund products generate positive returns throughout subprime crisis.
Assets managed by Aeneas deployed into health care private equity and direct investments.
Aeneas Group builds healthtech partnership with Aptorum Group, a multi-disciplinary medical innovations platform based in HK.
Aeneas Capital initiates to expand its licenses with the SFC in HK to include dealing and advising in securities; Aeneas expands partnerships with healthtech companies specializing in neuro, infectious diseases, and robotic surgery devices.
Aeneas Capital, LLC. established in New Jersey, U.S.A. to set up a FINRA regulated broker dealer (in progress); Aeneas Group establishing a full-service banking license in Europe (in progress).
June Initiate Private Sale; Aeneas Capital granted expanded licenses by the SFC in HK to deal and advise in securities; Community investors outreach.
Expand team: Developers; 1st pipeline healthtech; ICO launch; Launch first generation smart wallet & infrastucture (AEN Connect).
Second generation: AENX trading exchange.
Third generation: AENCO prime brokerage platform; Ongoing service & expansion of pipeline HealthTech partners.
Put this code to your website